| Jeffery Tin Wai Kwock, MD | |
|
209 Martin Luther King Jr Way, Tacoma, WA 98405-4265 | |
| (253) 596-3300 | |
| (253) 596-3301 |
| Full Name | Jeffery Tin Wai Kwock |
|---|---|
| Gender | Male |
| Speciality | Dermatology |
| Location | 209 Martin Luther King Jr Way, Tacoma, Washington |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1386105492 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207N00000X | Dermatology | MD61454503 (Washington) | Primary |
| Entity Name | Kaiser Foundation Health Plan Of Washington |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1396810701 PECOS PAC ID: 9032022579 Enrollment ID: O20031112000454 |
News Archive
With winter fast approaching, RMIT University is helping people to beat coughs, colds and other winter nasties with a free introductory offer for Chinese medicine treatment.
That moment when you step on the gas pedal a split second before the light changes, or when you tap your toes even before the first piano note of Camila Cabello's "Havana" is struck. That's anticipatory timing.
The paper, put together by a team of scientists based in the United Kingdom and Italy, also underscored the need for healthcare policies to account for the very real possibility of inadequate protective personal equipment (PPE), staff and hospital capacity, aggravated by the increased number of pediatric infections.
Antidepressant medications taken by pregnant women are associated with increased rates of preterm birth. This finding reinforces the notion that antidepressants should not be used by pregnant women in the absence of a clear need that cannot be met through alternative approaches, say researchers from Brigham and Women's Hospital, Vanderbilt University, MetroWest Medical Center, and Tufts Medical Center.
Taligen Therapeutics, a biotechnology company developing therapies that regulate the complement system to treat inflammatory and immune diseases, announced today that the U.S. Patent and Trademark Office has issued U.S. Patent No. 7,759,304, entitled "Targeting Complement Factor H For Treatment of Diseases", covering the composition of matter for its lead product candidate, TT30, a novel fusion protein that selectively binds to complement activated cells to locally regulate the complement system.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Jeffery Tin Wai Kwock, MD 209 Martin Luther King Jr Way, Tacoma, WA 98405-4267 Ph: (253) 596-3300 | Jeffery Tin Wai Kwock, MD 209 Martin Luther King Jr Way, Tacoma, WA 98405-4265 Ph: (253) 596-3300 |
News Archive
With winter fast approaching, RMIT University is helping people to beat coughs, colds and other winter nasties with a free introductory offer for Chinese medicine treatment.
That moment when you step on the gas pedal a split second before the light changes, or when you tap your toes even before the first piano note of Camila Cabello's "Havana" is struck. That's anticipatory timing.
The paper, put together by a team of scientists based in the United Kingdom and Italy, also underscored the need for healthcare policies to account for the very real possibility of inadequate protective personal equipment (PPE), staff and hospital capacity, aggravated by the increased number of pediatric infections.
Antidepressant medications taken by pregnant women are associated with increased rates of preterm birth. This finding reinforces the notion that antidepressants should not be used by pregnant women in the absence of a clear need that cannot be met through alternative approaches, say researchers from Brigham and Women's Hospital, Vanderbilt University, MetroWest Medical Center, and Tufts Medical Center.
Taligen Therapeutics, a biotechnology company developing therapies that regulate the complement system to treat inflammatory and immune diseases, announced today that the U.S. Patent and Trademark Office has issued U.S. Patent No. 7,759,304, entitled "Targeting Complement Factor H For Treatment of Diseases", covering the composition of matter for its lead product candidate, TT30, a novel fusion protein that selectively binds to complement activated cells to locally regulate the complement system.
› Verified 2 days ago
Dr. Amanda J Laska-trump, M.D. Dermatology Medicare: Medicare Enrolled Practice Location: 9040a Jackson Ave, Tacoma, WA 98431 Phone: 253-968-1365 | |
Dr. Vijay Vanchinathan, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 209 Martin Luther King Jr Way, Tacoma, WA 98405 Phone: 253-596-3300 | |
Jill R. Rosenthal, M.D. Dermatology Medicare: Medicare Enrolled Practice Location: 209 Martin Luther King Jr Way, Tacoma, WA 98405 Phone: 253-596-3300 | |
Angela L Ladenburg, ARNP Dermatology Medicare: Medicare Enrolled Practice Location: 4707 S 19th St Ste 130, Tacoma, WA 98405 Phone: 253-752-7705 Fax: 253-752-0113 | |
Dr. Pitiporn Suwattee, M.D. Dermatology Medicare: Medicare Enrolled Practice Location: 209 Martin Luther King Jr Way, Tacoma, WA 98405 Phone: 253-596-3300 | |
Aaron Pace, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 1901 S Union Ave Ste B3003, Tacoma, WA 98405 Phone: 253-572-2842 |